Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting on DLB
Externally-Led Patient-Focused Drug Development (EL-PFDD) Meeting on DLB
It’s unanimous. Safe and effective drugs are urgently needed to treat dementia with Lewy bodies (DLB). Are you ready to make an impact on future treatments? Don’t miss this opportunity to share your lived experience with DLB with the FDA in this special, once-in-a-lifetime, public event. Your voice matters! The Lewy Body Dementia Association in collaboration […]